scispace - formally typeset
A

Angelica Nordin

Researcher at Umeå University

Publications -  11
Citations -  438

Angelica Nordin is an academic researcher from Umeå University. The author has contributed to research in topics: Gene & Myopathy. The author has an hindex of 6, co-authored 9 publications receiving 274 citations.

Papers
More filters
Journal ArticleDOI

A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories

TL;DR: It is proposed that Southern blotting techniques should be the gold standard, and be made obligatory in a clinical diagnostic setting, because of the wide range seen in genotyping results.
Posted ContentDOI

Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Wouter van Rheenen, +212 more
- 18 Mar 2021 - 
TL;DR: All ALS associated signals combined reveal a role for perturbations in vesicle mediated transport and autophagy, and provide evidence for cell-autonomous disease initiation in glutamatergic neurons.
Journal ArticleDOI

Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD

TL;DR: The size of hexanucleotide expansions in C9orf72 in neural and non-neural tissues from 18 autopsied ALS and FTD patients with repeat expansion in blood are estimated and it is found that repeat sizes up to 15 are stable, as no size variation between blood, brain and spinal cord was found.
Journal ArticleDOI

Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice

TL;DR: The mice data confirm a fundamental role for ISCU in mammals and further support tissue-specific splicing as the major mechanism limiting the phenotype to skeletal muscle in HML.
Journal ArticleDOI

The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1.

TL;DR: PTBP1 was found to repress the defective splicing of ISCU, resulting in a drastic loss of mutant transcripts, and IGF2BP1 and RBM39 shifted the splicing ratio toward the incorrect splice form.